Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2083071121', 'doi': 'https://doi.org/10.1016/s0968-0896(02)00031-7', 'title': 'Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE1 and 9-β-halo derivatives with improved stability', 'display_name': 'Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE1 and 9-β-halo derivatives with improved stability', 'publication_year': 2002, 'publication_date': '2002-06-01', 'ids': {'openalex': 'https://openalex.org/W2083071121', 'doi': 'https://doi.org/10.1016/s0968-0896(02)00031-7', 'mag': '2083071121', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11937333'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0968-0896(02)00031-7', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S10422866', 'display_name': 'Bioorganic & Medicinal Chemistry', 'issn_l': '0968-0896', 'issn': ['0968-0896', '1464-3391'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101981160', 'display_name': 'Toru Maruyama', 'orcid': 'https://orcid.org/0000-0001-6543-4377'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Toru Maruyama', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045914141', 'display_name': 'Masaki Asada', 'orcid': 'https://orcid.org/0000-0002-7117-5962'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masaki Asada', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088568879', 'display_name': 'Taro Shiraishi', 'orcid': 'https://orcid.org/0000-0002-6540-8029'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tai Shiraishi', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104102001', 'display_name': 'Hideyuki Yoshida', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hideyuki Yoshida', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077691716', 'display_name': 'Takayuki Maruyama', 'orcid': 'https://orcid.org/0000-0003-2205-8310'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takayuki Maruyama', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002066699', 'display_name': 'Shuichi Ohuchida', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Shuichi Ohuchida', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044537872', 'display_name': 'Hisao Nakai', 'orcid': 'https://orcid.org/0000-0001-9633-0255'}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hisao Nakai', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034492568', 'display_name': 'Kazuaki Kondo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Kigen Kondo', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5051760258', 'display_name': 'Masaaki Toda', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210112155', 'display_name': 'Ono Pharmaceutical (Japan)', 'ror': 'https://ror.org/022jefx64', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210112155']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masaaki Toda', 'raw_affiliation_strings': ['Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan'], 'affiliations': [{'raw_affiliation_string': 'Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan', 'institution_ids': ['https://openalex.org/I4210112155']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3690, 'currency': 'USD', 'value_usd': 3690, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.272, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 31, 'citation_normalized_percentile': {'value': 0.813505, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '10', 'issue': '6', 'first_page': '1743', 'last_page': '1759'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10678', 'display_name': 'Cyclooxygenase-2 Inhibitors in Inflammation and Cancer', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10678', 'display_name': 'Cyclooxygenase-2 Inhibitors in Inflammation and Cancer', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12910', 'display_name': 'Metabolism and Function of Arachidonic Acid Derivatives', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/1303', 'display_name': 'Biochemistry'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10756', 'display_name': 'Mechanisms of Estrogen Receptor Signaling', 'score': 0.9942, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/chemical-stability', 'display_name': 'Chemical stability', 'score': 0.5650177}, {'id': 'https://openalex.org/keywords/moiety', 'display_name': 'Moiety', 'score': 0.54224265}, {'id': 'https://openalex.org/keywords/chemical-modification', 'display_name': 'Chemical modification', 'score': 0.44938272}, {'id': 'https://openalex.org/keywords/structure–activity-relationship', 'display_name': 'Structure–activity relationship', 'score': 0.42637897}, {'id': 'https://openalex.org/keywords/receptors', 'display_name': 'Receptors', 'score': 0.423559}], 'concepts': [{'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.93496543}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.8747088}, {'id': 'https://openalex.org/C114373084', 'wikidata': 'https://www.wikidata.org/wiki/Q273499', 'display_name': 'Chemical synthesis', 'level': 3, 'score': 0.6998968}, {'id': 'https://openalex.org/C118792377', 'wikidata': 'https://www.wikidata.org/wiki/Q108584245', 'display_name': 'Selectivity', 'level': 3, 'score': 0.58421767}, {'id': 'https://openalex.org/C186399102', 'wikidata': 'https://www.wikidata.org/wiki/Q903517', 'display_name': 'Chemical stability', 'level': 2, 'score': 0.5650177}, {'id': 'https://openalex.org/C2776568683', 'wikidata': 'https://www.wikidata.org/wiki/Q23005640', 'display_name': 'Moiety', 'level': 2, 'score': 0.54224265}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.522161}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.4938646}, {'id': 'https://openalex.org/C184133267', 'wikidata': 'https://www.wikidata.org/wiki/Q5090480', 'display_name': 'Chemical modification', 'level': 2, 'score': 0.44938272}, {'id': 'https://openalex.org/C193042331', 'wikidata': 'https://www.wikidata.org/wiki/Q1772003', 'display_name': 'Structure–activity relationship', 'level': 3, 'score': 0.42637897}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.42250744}, {'id': 'https://openalex.org/C21951064', 'wikidata': 'https://www.wikidata.org/wiki/Q899212', 'display_name': 'Combinatorial chemistry', 'level': 1, 'score': 0.41093242}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.3531626}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.18508157}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.17326266}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C161790260', 'wikidata': 'https://www.wikidata.org/wiki/Q82264', 'display_name': 'Catalysis', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D011459', 'descriptor_name': 'Prostaglandins E, Synthetic', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011459', 'descriptor_name': 'Prostaglandins E, Synthetic', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D018078', 'descriptor_name': 'Receptors, Prostaglandin E', 'qualifier_ui': 'Q000819', 'qualifier_name': 'agonists', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016466', 'descriptor_name': 'CHO Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002118', 'descriptor_name': 'Calcium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002118', 'descriptor_name': 'Calcium', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D006224', 'descriptor_name': 'Cricetinae', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000242', 'descriptor_name': 'Cyclic AMP', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000242', 'descriptor_name': 'Cyclic AMP', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D015195', 'descriptor_name': 'Drug Design', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004355', 'descriptor_name': 'Drug Stability', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015394', 'descriptor_name': 'Molecular Structure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011459', 'descriptor_name': 'Prostaglandins E, Synthetic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011459', 'descriptor_name': 'Prostaglandins E, Synthetic', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D018078', 'descriptor_name': 'Receptors, Prostaglandin E', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018078', 'descriptor_name': 'Receptors, Prostaglandin E', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D058309', 'descriptor_name': 'Receptors, Prostaglandin E, EP4 Subtype', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015290', 'descriptor_name': 'Second Messenger Systems', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015290', 'descriptor_name': 'Second Messenger Systems', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013379', 'descriptor_name': 'Substrate Specificity', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0968-0896(02)00031-7', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S10422866', 'display_name': 'Bioorganic & Medicinal Chemistry', 'issn_l': '0968-0896', 'issn': ['0968-0896', '1464-3391'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11937333', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/6', 'display_name': 'Clean water and sanitation', 'score': 0.43}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 12, 'referenced_works': ['https://openalex.org/W1975443701', 'https://openalex.org/W1978506520', 'https://openalex.org/W1984677219', 'https://openalex.org/W2024658205', 'https://openalex.org/W2036963672', 'https://openalex.org/W2040939027', 'https://openalex.org/W2046942872', 'https://openalex.org/W2047797775', 'https://openalex.org/W2084615605', 'https://openalex.org/W2088536956', 'https://openalex.org/W2123440552', 'https://openalex.org/W2334675457'], 'related_works': ['https://openalex.org/W4385702077', 'https://openalex.org/W4367849741', 'https://openalex.org/W4247703407', 'https://openalex.org/W4245369115', 'https://openalex.org/W2354510408', 'https://openalex.org/W2317064019', 'https://openalex.org/W2305602491', 'https://openalex.org/W2070822785', 'https://openalex.org/W2054073249', 'https://openalex.org/W1967372833'], 'abstract_inverted_index': {'To': [0], 'identify': [1], 'a': [2, 36], 'new': [3, 37], 'selective': [4], 'EP4-agonist': [5], 'with': [6], 'improved': [7], 'chemical': [8, 11, 24, 38], 'stability,': [9], 'further': [10], 'modification': [12, 25], 'of': [13, 26, 30, 41, 85], 'those': [14], 'reported': [15], 'previously': [16], 'was': [17], 'continued.': [18], 'We': [19], 'focused': [20], 'our': [21], 'attention': [22], 'on': [23], 'the': [27, 47, 56, 86], 'α': [28], 'chain': [29, 45], '3,7-dithiaPGE1': [31], 'and': [32, 62, 68, 76, 93, 99], 'selected': [33], '5-thiaPGE1': [34], 'as': [35], 'lead.': [39], 'Introduction': [40], 'an': [42, 80], 'optimized': [43], 'ω': [44], 'to': [46, 82], '5-thiaPG': [48], 'skeleton': [49], 'afforded': [50], 'm-methoxymethyl': [51], 'derivative': [52], '33a,': [53], 'which': [54], 'showed': [55, 95], 'most': [57], 'potent': [58, 96], 'EP4-receptor': [59], 'agonist': [60, 97], 'activity': [61, 98], 'good': [63, 100], 'subtype-selectivity': [64], 'both': [65], 'in': [66, 69, 79], 'vitro': [67], 'vivo.': [70], '9β-HaloPGF': [71], 'derivatives': [72], 'were': [73], 'also': [74, 106], 'synthesized': [75], 'biologically': [77], 'evaluated': [78], 'attempt': [81], 'block': [83], 'self-degradation': [84], 'β-hydroxyketone': [87], 'moiety.': [88], 'Among': [89], 'these': [90], 'series,': [91], '39a': [92], '39b': [94], 'subtype-selectivity.': [101], 'Structure–activity': [102], 'relationships': [103], '(SARs)': [104], 'are': [105], 'discussed.': [107]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2083071121', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 2}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-09-19T21:51:55.233079', 'created_date': '2016-06-24'}